ArvinIG

Hi @dcy, Unfortunately the IG app is not available on the App store in Taiwan. All the best - Arvin

Hi @dcy, MT4 is a third-party software that we use, but it is not our app. It should look similar to this : I will try to get more information on the App store in Taiwan. - Arvin

Hi dcy, Could you please send a screenshot of your search result when you type "ig trading' on the App Store? Thank you - Arvin

HI @Dongold, Could you please clarify where did you send all these statements? Our Anti-Money Laundering Policies require IG to very all deposits made through BPay as the transactions are encrypted, IG needs to verify that the funds are coming from an account under your name to be returned. Please email Helpdesk.au@ig.com with your Statements showing the relevant deposits made to IG to be verified. Once verified you will be able to withdraw your funds. Thank you - Arvin

Hi @MakMans, We used to offer SWAP free accounts for Dubai residents however we don't offer this type of account anymore. Thanks - Arvin

Hi, We used to offer SWAP free accounts for Dubai residents however we don't offer this type of account anymore. Thanks - Arvin

Hi @GuyHarding, About 3 weeks ago this communication went out: "Due to a change in the exchange’s market data policy, we won’t be able to provide free live spread betting prices on Swedish, Danish or Finnish shares from 2 August 2021. Delayed prices will also not be available. Should you wish to continue receiving realtime exchange prices, you can opt to pay for them by logging in to our desktop site, clicking on the ‘settings’ tab in My IG and selecting ‘data feeds’ from the menu. If you place at least one trade per calendar month, you will be rebated the exchange fee at the end of the month. If you choose not to opt-in for live data feeds, you’ll no longer receive any prices for Swedish, Danish or Finnish stocks." You can find the OMX feed in Settings > Data feeds > Spread bet: I hope that it helps. All the best - Arvin

Hi @Pogwyl, You will need to complete your W-8BEN form online from My IG > Settings > Dealing US stock > ">" : Complete the online form, once completed successfully, your form status will change accordingly. More details here. All the best - Arvin

Hi Wai @StevenCham, For Share trading we can only offer stocks listed on exchanges in the following countries: Unfortunately, we won't be able to add GLO for share dealing account. All the best - Arvin

Although airline groups IAG and easyJet are seeing uneven paces of recovery across their key markets, research teams mostly kept a rosy outlook. Source: Bloomberg Shares International Airlines Group EasyJet Airline British Airways Iberia International Consolidated Airlines Group (LON: IAG) share price rises 1.3% to 169.98 pence easyJet (LON: EZJ) reaches 828.60 pence per share The transatlantic reopening may be the next big catalyst, analysts say IAG’s rebound will depend on its key unit British Airways Interested in trading IAG and easyJet shares? Open an account with us to get started. IAG and easyJet stock prices: what’s the latest? Shares of Anglo-Spanish airline holding company International Consolidated Airlines Group SA, also known as IAG, jumped 1.3% to finish Wednesday at 168.98 pence. British low-cost airline group easyJet’s stock gained 0.6% to close at 828.60 pence. As of Wednesday, research teams were largely bullish on both counters, Bloomberg data showed. For easyJet, 16 analysts recommended ‘buy’, seven said ‘hold’, while two suggested ‘sell’. Their average 12-month target price on easyJet was 1,046.53 pence. Meanwhile, IAG attracted 20 ‘buy’ calls, seven ‘hold’ ratings, and one ‘sell’ recommendation. The average target price stood at 227.85 pence. IAG’s performance hinges on British Airways’ international recovery Barclays stayed ‘neutral’ on the European transport sector, rating IAG ‘overweight’ and easyJet ‘equal-weight’. Although some demand is returning, there remains balance-sheet risk in the sector, with wait-and-see approaches for IAG and easyJet, the bank’s analysts said. All eyes will be on September for the two-way transatlantic reopening, which is the next big catalyst for network airlines, Barclays added. For IAG, there is clear varied performance across the group, with fewer restrictions supporting performance at Iberia and Vueling, while the restricted transatlantic market and UK/Irish government measures are impeding British Airways and Aer Lingus, Barclays wrote. Bloomberg Intelligence (BI) wrote that the group’s recovery will hinge on its key unit British Airways’ international routes. British Airways is hampered by long-haul flight exposure, with consensus not seeing a return to pre-pandemic sales until at least 2024. ‘Capacity has been cut, but transatlantic travel is needed to rebuild profit, in our view,’ BI analysts said. Digital safety passports may unleash some European demand for Iberia and Vueling, which have also adapted to target dometic travel in Spain. These certificates can also help Aer Lingus rejoin the skies, BI added. What’s your view on IAG and easyJet? Take positions on both airline stocks today Trade over 16,000 international shares from zero commission with us, the UK’s No.1 trading provider.* Learn more about trading shares with us, or open an account to get started today. *Based on revenue excluding FX (published financial statements, June 2020) Analysts mixed on easyJet shares On easyJet, Deutsche Bank sees scope for the budget carrier to carry 95.5 million passengers in its fiscal year to September 2023, just shy of the 96.1 million carried in FY2019. It reiterated ‘buy’ with a 1,150-pence price target. Barclays noted that easyJet is seeing better performance in continental Europe than in the UK. Possible catalysts for EZJ include the second phase of the new cabin-bag policy, to be introduced in autumn; the £500 million cost-out programme, on target for year-end; and the upcoming balance-sheet review with its full-year results. JPMorgan remained ‘neutral’ on easyJet, due to uncertainty over the Delta variant of the coronavirus and uncertainty over the outcome of the capital structure review. Cost headwinds such as higher interest charges and higher aircraft ownership costs could also offset most of the savings the airline has targeted since the pandemic started, JPMorgan said. Kelvin Ong | Financial writer, Singapore 12 August 2021

Hi @Naoto, No it won't change as it is specific to your region. FINRA is a Regulator in the USA. If you are outside the US it won't apply. All the best - Arvin

Hi @Speedbird168l, You can try to ask webapisupport@ig.com, they might be able to help you. All the best - Arvin

Hi @Funky_Gibbon, You can send an email to webapisupport@ig.com with screenshots. They should be able to assist. All the best - Arvin

Hi @NarayananIG, The demo account does not have the same data feed as the live account although they are very similar. Please reach out to helpdesk.uk@ig.com to solve your query. Thank you - Arvin

Hi @Jak123, You can send your query with a screenshot to helpdesk.uk@ig.com for some assistance. All the best - Arvin

Hi @MFRAGLER711, I can see that the helpdesk sent you out a statement. You may need to extend the dates of research as the annual statement would have been provided after the 30th June 2021. Thank you - Arvin

Hi @BullHorn, Thank you for confirming, could you please send a screenshot of your MarketWatch please? I should look like this, not with a black background. Have you tried to reinstall MT4? https://www.ig.com/us/trading-platforms/metatrader-4/download-mt4 Thank you - Arvin

Hi @JacFlowTrade, It should be all sorted now, and you should be able to force open positions ( opposite directions). All the best - Arvin

Hi @JacFlowTrade, I will send you an email with further information. Thank you - Arvin

Hi @BullHorn, Are you referring to the market list / Watchlist on the IG plaform? Or the Market watch on MT4? If you are referring the screenshot below: Then you can change the background in the settings : I hope that it helps ! All the best - Arvin

Hi @FSADXB, I have check all the stocks you mentioned. Effectively they are not showing up on the demo account. But on a live account I was able to find them, they are available on the live platform: I hope that it helps ! All the best - Arvin

Hi All, Your feedbacks/suggestions will be forwarded to the relevant department. Unfortunately, at this point there is no information about a Junior ISA to be added on IG. All the best - Arvin

Covid-19 vaccine maker Moderna’s stock has been on a tear this year, hitting record highs. Source: Bloomberg Shares Moderna COVID-19 vaccine United States BioNTech Pfizer Moderna (Nasdaq: MRNA) share price falls to US$456.76 per share The US biotech said it will not exceed its 2021 vaccine production target Moderna’s jab may be more effective against the Delta variant than its rival’s shot, a study suggested Feeling bullish or bearish about Moderna? Open an account with us to start trading the stock. Moderna snaps record-setting stock rally Shares of Covid-19 vaccine manufacturer Moderna halted its gains, despite upcoming new guidance on the need for booster shots. The US firm declined 5.7% to US$456.76 on Tuesday amid a broader rout in biotech stocks, after it had jumped to its all-time record of US$484.47 on Monday. Year-to-date, Moderna has soared 308.8% to fresh highs. The price gains came as more governments and employers have imposed vaccine requirements. Last Thursday, Moderna said its jab stayed about 93% effective through six months after the second dose, barely changed from the 93% efficacy in the original trial. Nonetheless, the drugmaker expects booster shots to be necessary before the winter season, as antibody levels would likely fall. Within 17 analysts, six rated MRNA ‘buy’, seven gave ‘hold’ calls, while four recommended ‘sell’ as of Tuesday. Their average 12-month target price was US$277.07, Bloomberg data showed. Goldman Sachs last Friday upped its target to US$461 while Barclays eyed a Wall Street high of US$463, but Moderna’s shares shot past those levels on Monday. Jefferies, which recommended ‘hold’ and targeted US$425, foresees booster shots becoming available by 2022. What’s your view on Moderna? Take a long or short position today Trade over 16,000 international shares from zero commission with us, the UK’s No.1 trading provider.* Learn more about trading shares with us, or open an account to get started today. *Based on revenue excluding FX (published financial statements, June 2020) Where next after better-than-expected turnover? Revenue for 2Q 2021 reached US$4.4 billion, exceeding expectations of US$4.2 billion based on a Refinitiv poll of 10 analysts. In its second-quarter results call last week, Moderna said it will not produce more than the 800 million to 1 billion vaccine doses that it targeted for 2021, as it is 'capacity constrained'. Moderna has inked advance purchase agreements for anticipated product sales of US$20 billion for 2021. For delivery next year, it has already signed agreements for some US$12 billion of product sales with options for another US$8 billion. Investors are now focusing on the sustainability of Moderna’s vaccine income, in terms of the need for additional doses and over what time period, Bloomberg Intelligence analysts wrote last Friday. ‘Opening the lid on the current order status for 2022 helps to justify some of the company’s optimism, though uncertainties remain,’ they added. Is Moderna superior to Pfizer against the Delta variant? Two reports posted on Sunday, before peer review, indicated that the mRNA vaccine from Moderna may be more effective against the Delta variant of the coronavirus than the shot from Pfizer and BioNTech. One study involved more than 50,000 patients and looked into the effectiveness of the vaccines against infection in July, when the Delta variant was predominant, Reuters reported. Although the effectiveness of Moderna’s jab declined to 76% in July, from 86% in early 2021, the Pfizer/BioNTech vaccine’s effectiveness slid to 42% from 76%, the researchers found. Kelvin Ong | Financial writer, Singapore | Publication date: Wednesday 11 August 2021 21:30

We examine the highlights from the bank’s full-year report, released on Wednesday, August 11. Source: Bloomberg Shares Dividend Bank Share repurchase Price Stock CBA share price runs hot Heading into today’s FY21 release, the Commonwealth Bank of Australia (ASX: CBA) share price spent the early-parts of this week flirting with all-time highs. Yesterday we mused that excellence got us there, while also wondering if excellence could keep the stock there. The FY21 results the bank handed down were rather excellent, with the bank reporting firm earnings growth, an impressive capital position, and announcing a solid dividend and hefty buy-back program. Despite running up before the results, the CBA share price would continue to rise on Wednesday – opening at $108.75 per share. At the time of writing CBA traded at $107.88 per share, up 1.24% for the session. A mammoth buy-back The headline result from the FY21 release really was CBA’s announcement that it would pursue a $6 billion off-market, share buy-back. Indeed, while analysts were expecting the announcement of such capital management initiatives – the quantum of the buy-back program looks to have come in ahead of expectations. As analysts from Citi put it 'While the buy-back was slighlty larger than our forecast $5bn, it appears CBA's rationale for $6bn revolves around the $6.2bn of excess capital generated by divestments.' CBA highlighted its strong operational performance as a building block of this buy-back, while the bank’s Chairman, Catherine Livingstone noted that ‘After careful consideration, [the CBA] Board has determined that the Buy-Back is the most efficient and value-enhancing strategy to distribute CBA's surplus capital and franking credits.' The buyback program will see approximately 3.5% of CBA’s outstanding stock ‘taken offline’. FY21 results in focus Beyond the buy-back, the bank posted a solid set of full-year (FY21) results, reporting stronger profits, slightly higher revenues, and a robust dividend. On the top-line, the bank reported total income of $24.15 billion, representing a year-on-year increase of 1.7%. By comparison, across the full-year, CBA's net interest margin fell 4 basis points to 2.03%, as low rates continue to erode bank margins. While not company’s specific, management, in commenting on the outlook, said 'we expect a number of headwinds to impact Group NIM in the next financial years.' Operational expenses also increased in FY21, gaining 3.3% to come in at $11.3 billion; while the bank maintained its ‘unquestionably strong’ capital position, reporting a CET1 ratio of 13.1%. Off the back of all that, net profits experienced solid growth, with statutory NPAT hitting $8.84 billion (+19.7% year-on-year), while cash NPAT came in at $8.65 billion (+19.8% year-on-year). Lastly, the bank declared a fully-franked Final dividend of $2.00 per share – taking CBA's full-year dividends to $3.50 per share. While CBA maintained good dividends throughout the pandemic – this final dividend in conjunction with the $6.0 billion buy-back program – will likely play well with income-inclined investors. Do you have a view on CBA? Whatever you think, you can use CFDs to trade both rising and falling markets, through IG’s world-class trading platform now. For example, to buy (long) or sell (short) a stock using CFDs, follow these steps: Create an IG Trading Account or log in to your existing account Enter <company name> in the search bar and select it Choose your position size Click on ‘buy’ or ‘sell’ in the deal ticket Confirm the trade Alternatively, you can invest in shares directly through our share trading service. Shane Walton | Financial Writer, Australia 11 August 2021

Hi All, Could you please clarify what charts you are looking and at what time? Please send screenshots to helpdesk.uk@ig com with the charts you are comparing with. Thank you - Arvin